Aldeyra Therapeutics, Inc. (ALDX)
4.65
-0.54
(-10.49%)
USD |
NASDAQ |
Mar 05, 16:00
4.645
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics Cash from Investing (Quarterly) : 16.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -3.812M |
| MediciNova, Inc. | 0.00 |
| Altimmune, Inc. | -149.32M |
| AbbVie, Inc. | -1.463B |
| Actinium Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.299M |
| Free Cash Flow | -33.35M |
| Free Cash Flow Per Share (Quarterly) | -0.0881 |
| Free Cash Flow to Equity (Quarterly) | -5.286M |
| Free Cash Flow to Firm (Quarterly) | -4.824M |
| Free Cash Flow Yield | -11.94% |